tiprankstipranks
Galapagos price target lowered to EUR 35 from EUR 36 at Morgan Stanley
PremiumThe FlyGalapagos price target lowered to EUR 35 from EUR 36 at Morgan Stanley
2M ago
Galapagos assumed with an Equal Weight at Morgan Stanley
PremiumThe Fly
Galapagos assumed with an Equal Weight at Morgan Stanley
2M ago
Galapagos price target lowered to $41 from $44 at BofA
PremiumThe Fly
Galapagos price target lowered to $41 from $44 at BofA
2M ago
Galapagos enters GMP manufacturing agreement with Thermo Fisher
PremiumThe FlyGalapagos enters GMP manufacturing agreement with Thermo Fisher
4M ago
Galapagos collaborates with BridGene Biosciences for small molecule drugs
PremiumThe Fly
Galapagos collaborates with BridGene Biosciences for small molecule drugs
4M ago
BridGene in $27M collaboration and licensing pact with Galapagos
PremiumThe Fly
BridGene in $27M collaboration and licensing pact with Galapagos
4M ago
Galapagos signs manufacturing agreement for CAR-T cell therapy
PremiumThe FlyGalapagos signs manufacturing agreement for CAR-T cell therapy
6M ago
Galapagos reports first nine months FY23  revenue of EUR 448.9M
PremiumThe Fly
Galapagos reports first nine months FY23 revenue of EUR 448.9M
6M ago
Galapagos finishes strategic evaluation signs LOI for Jyseleca to  Alfasigma
PremiumThe Fly
Galapagos finishes strategic evaluation signs LOI for Jyseleca to Alfasigma
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100